Correlation Between Abcellera Biologics and HUTCHMED DRC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and HUTCHMED DRC, you can compare the effects of market volatilities on Abcellera Biologics and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and HUTCHMED DRC.

Diversification Opportunities for Abcellera Biologics and HUTCHMED DRC

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Abcellera and HUTCHMED is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Abcellera Biologics and HUTCHMED DRC

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the HUTCHMED DRC. But the stock apears to be less risky and, when comparing its historical volatility, Abcellera Biologics is 1.09 times less risky than HUTCHMED DRC. The stock trades about -0.03 of its potential returns per unit of risk. The HUTCHMED DRC is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,407  in HUTCHMED DRC on August 31, 2024 and sell it today you would earn a total of  436.00  from holding HUTCHMED DRC or generate 30.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  HUTCHMED DRC

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
HUTCHMED DRC 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, HUTCHMED DRC may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Abcellera Biologics and HUTCHMED DRC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and HUTCHMED DRC

The main advantage of trading using opposite Abcellera Biologics and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.
The idea behind Abcellera Biologics and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device